Accordingly, the absence of ERRα is able to impair tumorigenic potential in aggressive xenografted breast cancer cells where the ERRα/PGC-1α complex binds to a VEGF promoter region regulating its expression, and promoting tumor angiogenesis and invasion. This evidence concerns the gene ESRRA and breast carcinoma.